[HTML][HTML] Pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi

GS Stuart, A Moses, A Corbett, G Phiri… - Journal of acquired …, 2011 - ncbi.nlm.nih.gov
Pharmacokinetics and Pharmacodynamics of a Combined Oral Contraceptive and a Generic
Combined Formulation Antiretroviral in Malawi - PMC Back to Top Skip to main content NIH …

Steroid-releasing vaginal rings: a review

PJ Rowe - Fertility and Sterility: The Proceedings of the XIth World …, 1984 - Springer
The vaginal route of administration of contraceptive steroids offers a number of advantages
over oral or injectable preparations. Firstly, the device can be inserted, removed and …

Immediate postabortal contraception with NORPLANTR: Levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of …

H Kurunmäki, J Toivonen, PLA Lähteenmäki… - Contraception, 1984 - Elsevier
Six Silastic R levonorgestrel-releasing capsules, Norplant R, were introduced
subcutaneously into the ventral aspect of the left forearm or upper arm of thirteen patients …

A simple statistical test of parallelism in immunoassays

SZ Cekan, U Brodin - Analytical Letters, 1980 - Taylor & Francis
A simple test of parallelism in immunoassays is proposed. Various amounts of a biological
material are assayed and the concentrations are computed on the basis of a standard curve …

Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets

KA Abdalla, MM Shabaan, FZ Stanczyk - Contraception, 1992 - Elsevier
Ten women were treated daily with a standard dose contraceptive tablet containing 0.25 mg
levonorgestrel (LNG) in combination with 0.05 mg ethinylestradiol. Five women used the …

New delivery systems for d-norgestrel

E Weiner, A Victor, EDB Johansson - Acta Obstetricia et …, 1976 - Taylor & Francis
D-Ng has a longer biological half-life than any of the gestagenic steroids available presently
in market. The slow metabolic clearance does not appear to be due to any difficulties in the …

Silastic implants releasing estrone in the treatment of climacteric complaints

S Sipinen, P Lähteenmäki, T Luukkainen - Maturitas, 1980 - Elsevier
A study on continuous low-dose estrone treatment achieved with two different silastic
implants is presented. In the study the estrogen treatment was supplemented with the …

Pharmacokinetics of contraceptive steroids in humans

U Goebelsmann - Contraceptive steroids: pharmacology and safety, 1986 - Springer
In contrast to our longstanding and enormous clinical experience with contraceptive
steroids, most of our knowledge about the pharmacokinetics of these drugs in man has been …

Pharmacodynamics of Norplant R Implants

HA Nash, D N. Robertson - … Response: Regional Variability in Side-Effects …, 1994 - Springer
NORPLANT R subdermal implants comprise a contraceptive modality in which
levonorgestrel is continuously released from capsules placed beneath the skin. The …

The effect of levonorgestrel and estrone rods on male reproductive function

V Brache, F Alvarez-Sánchez, P León, F Schmidt… - Contraception, 1982 - Elsevier
The effect on spermatogenesis of the implantation of six rods containing levonorgestrel and
three estrone rods was studied in seven volunteers aged 32–40, with normal pre-treatment …